Yi Luo

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Yi Luo, Haowen Xiao, Xiaoyu Lai et al. · Blood · 2014 · 196 citations

Life Sciences, Hematology, Immunology +16

Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway

Kaimin Hu, Yanjun Gu, Lixia Lou et al. · Journal of Hematology & Oncology · 2015 · 156 citations · Full text

Medicine, Cell Biology, Oncology +16

Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia

Yongxian Hu, Zhao Wu, Yi Luo et al. · Clinical Cancer Research · 2016 · 134 citations

Life Sciences, Oncology, Pharmacology +17

The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030

Mengbao Du, Weiwei Chen, Ke Liu et al. · Journal of Oncology · 2022 · 127 citations · Full text

Medicine, Health Sciences, Oncology +17

First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation

Haowen Xiao, Jimin Shi, Yi Luo et al. · Blood · 2011 · 84 citations

Medicine, Genetics, Hematology +14